Dr. Ian Gilron is actively studying pain and treatments in Providence Care aimed at managing pain especially in the population with depression using treatment strategies such as repetitive transcranial magnetic stimulation of the brain (rTMS). He is the Director of Clinical Pain Research, Professor of Anesthesiology, and Biomedical Sciences, and Faculty in the Centre for Neuroscience Studies at Queen’s University in Kingston, Ontario, Canada. He has received continuous funding from the Canadian Institutes of Health Research (CIHR), and from the PSI Foundation (Ontario), since 2000 to support research, and research training programs, which study the mechanisms of, and treatments for, chronic and acute pain. Work from Dr. Gilron’s research team at Queen’s University has been published in the New England Journal of Medicine, Lancet, CMAJ, Pain, Anesthesiology and other journals. He has also co-authored neuropathic pain treatment guidelines from the Canadian Pain Society (2014) and the Neuropathic Pain Special Interest Group of the International Association for the Study of Pain (2015). Dr. Gilron serves on the Executive Committee of the Analgesic “ACTTION” partnership (acttion.org); is one of the Principal Investigators of the CIHR Strategy for Patient-Oriented Research Chronic Pain Network; and is the Chair of the Scientific Program Committee for the 2022 IASP World Congress on Pain.
Senior Associate Researcher at Providence Care